Anti-BMI1 Antibody, Rabbit Polyclonal sinobiological 100299-T08
$243.00
In stock
SKU
100299-T08
| Catalog No. | Size | Price (USD) |
| 100299-T08-100 | 100 µL | $251.64 |
General Information
| Product name | Anti-BMI1 Antibody, Rabbit Polyclonal |
| Validated applications | IHC-P (FAQ Protocol) |
| Species reactivity | Reacts with: Human |
| Specificity | Human Mouse (Species predicted to react based on 100% sequence homology) |
| Immunogen | A synthetic peptide corresponding to the C-terminus of the Human BMI1 |
| Preparation | Produced in rabbits immunized with a synthetic peptide corresponding to the C-terminus of the Human BMI1, and purified by antigen affinity chromatography. |
| Source | Polyclonal Rabbit IgG |
| Purification | Protein A & Antigen Affinity |
| Formulation | 0.2 μm filtered solution in PBS |
| Conjugate | Unconjugated |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
Synonyms: Anti-flvi-2/bmi-1 Antibody; Anti-FLVI2/BMI1 Antibody; Anti-PCGF4 Antibody; Anti-RNF51 Antibody
Image / Experimental Information
| Image 1 Description | Immunochemical staining of human BMI1 in human muscle with rabbit polyclonal antibody at 1:100 dilution, formalin-fixed paraffin embedded sections. |
| Image 1 Alt Text | Human BMI1 Immunohistochemistry(IHC) 37231 |
| Image 1 URL | Source image |
-HD17MY0512-100-human- muscle-IHC-P.png){kind=link}
Background Information
| Full Name | BMI1 proto-oncogene, polycomb ring finger |
| Description | Polycomb group member protein BMI1 is involved in maintaining cell identity, proliferation, differentiation and human oncogenesis. BMI1 mRNA expression in whole blood might represent a new biomarker for the diagnosis and prognosis of NSCLC. In human myoblasts, BMI1 overexpression increases mitochondrial activity, leading to an enhanced energetic state with increased ATP production and concomitant protection against DNA damage both in vitro and upon xenografting in a severe dystrophic mouse model. BMI1 inhibition suppressed proliferation of leukemia cells through NOTCH signaling which functions downstream of BMI1, suggesting that BMI1 inhibitors can be candidate targeted drugs against leukemia. BMI1 decreases ATR activation through a mechanism that involves binding to TOPBP1 and/or ATR. BMI1 over-expression may be useful in identifying patients who might benefit from novel therapies directed at reversing the chromatin-modifying functions of BMI1. |
Reviews
Write Your Own Review